Sarvodaya Healthcare, Transcell Oncologics partner to offer predictive genetic analysis

June 01, 2022 | Wednesday | News

HEMATO PREGEN is one-of-its-kind Predictive Genetic Analysis of the genetic material (RNA/DNA) in our body to identify the genetic anomalies that cause up to 90% of genetic diseases in humans

Image Credit: Shutterstock

Image Credit: Shutterstock

Sarvodaya Hospital, Faridabad and Transcell Oncologics, a stem cell technology-based biotech company in Hyderabad, have announced that HEMATO PREGEN, a comprehensive test providing predictive health signature analysis services from Transcell will now be available at Sarvodaya Medicentre at GK Enclave 1 in New Delhi.

HEMATO PREGEN provides analysis of 20,000+ genes, which are known as predictive biomarkers, covering 90 per cent of diseases resulting from gene anomalies.

The test is based on Next Generation/Whole Exome Sequencing (NGS/WES) and assessment by GenePoweRx, a homegrown trained Bioinformatics Engine with AI & ML tools and endorsed by Memorial Sloan Kettering Cancer Center, USA, in line with the Broad Institute’s human genome project. The report takes up to 45 days and a post-counselling session is offered at the clinic thereafter.



Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy